Soleus Capital Management, L.P. has filed its 13F form on February 14, 2025 for Q4 2024 where it was disclosed a total value porftolio of $1.44 Billion distributed in 81 stocks.

Among their holdings, we can observe that their the top five positions include companies like: Novo Cure LTD with a value of $81.6M, Tg Therapeutics, Inc. with a value of $80.7M, Biomarin Pharmaceutical Inc with a value of $65.8M, Krystal Biotech, Inc. with a value of $56.1M, and Grifols Sa with a value of $49.1M.

Examining the 13F form we can see an increase of $259M in the current position value, from $1.18B to 1.44B.

Soleus Capital Management, L.P. is based out at Greenwich, CT

Below you can find more details about Soleus Capital Management, L.P. portfolio as well as his latest detailed transactions.

Portfolio value $1.44 Billion
Healthcare: $1.17 Billion
ETFs: $270 Million

Stock Holdings Table

Stock Market Cap. Holding Value (Reported) # of Shares. Last Trade Trade History

Summary

  • Portfolio
  • No. of Stocks 81
  • Current Value $1.44 Billion
  • Prior Value $1.18 Billion
  • Filing
  • Period Q4 2024
  • Filing Date February 14, 2025
  • Form Type 13F-HR
  • Activity in Q4 2024
  • New Purchases 24 stocks
  • Additional Purchases 21 stocks
  • Sold out of 0 stocks
  • Reduced holdings in 23 stocks
Track This Portfolio

Track Soleus Capital Management, L.P. Portfolio

Follow Soleus Capital Management, L.P. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Soleus Capital Management, L.P., based on Form 13F filings with the SEC.

News

Stay updated on Soleus Capital Management, L.P. with notifications on news.